Cargando…

Participation and Yield of a Lung Cancer Screening Program in Hebei, China

OBJECTIVE: Lung cancer screening has been widely conducted in Western countries. However, population-based lung cancer screening programs in Hebei in China are sparse. Our study aimed to assess the participation rate and detection rate of positive nodules and lung cancer in Hebei province. METHOD: I...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Di, Shi, Jin, Li, Daojuan, Wu, Siqi, Jin, Jing, He, Yutong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784378/
https://www.ncbi.nlm.nih.gov/pubmed/35083151
http://dx.doi.org/10.3389/fonc.2021.795528
_version_ 1784638723561881600
author Liang, Di
Shi, Jin
Li, Daojuan
Wu, Siqi
Jin, Jing
He, Yutong
author_facet Liang, Di
Shi, Jin
Li, Daojuan
Wu, Siqi
Jin, Jing
He, Yutong
author_sort Liang, Di
collection PubMed
description OBJECTIVE: Lung cancer screening has been widely conducted in Western countries. However, population-based lung cancer screening programs in Hebei in China are sparse. Our study aimed to assess the participation rate and detection rate of positive nodules and lung cancer in Hebei province. METHOD: In total, 228 891 eligible participants aged 40–74 years were enrolled in the Cancer Screening Program in Hebei from 2013 to 2019. A total of 54 846 participants were evaluated as the lung cancer high-risk population by a risk score system which basically followed the Harvard Risk Index and was adjusted for the characteristics of the Chinese population. Then this high-risk population was recommended for low-dose computed tomography (LDCT) screening. And all participants attended annual passive follow-up, and the active follow-up interval was based on radiologist’s suggestion. All participants were followed-up until December 31, 2020. The overall, group-specific participation rates were calculated, and its associated factors were analyzed by a multivariable logistic regression model. Participation rates and detection of positive nodules and lung cancer were reported. RESULTS: The overall participation rate was 52.69%, where 28 899 participants undertook LDCT screening as recommended. The multivariable logistic regression model demonstrated that a high level of education, having disease history, and occupational exposure were found to be associated with the participation in LDCT screening. The median follow-up time was 3.56 person-years. Overall, the positive identification of lung nodules and suspected lung cancer were 12.73% and 1.46% through LDCT screening. After the native and passive follow-up, 257 lung cancer cases were diagnosed by lung cancer screening, and the detection rate of lung cancer was 0.89% in the screening group. And its incidence density was 298.72 per 100,000. Positive lung nodule rate and detection rate were increased with age. CONCLUSION: Our study identified personal and epidemiological factors that could affect the participation rate. Our findings could provide the guideline for precise prevention and control of lung cancer in the future.
format Online
Article
Text
id pubmed-8784378
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87843782022-01-25 Participation and Yield of a Lung Cancer Screening Program in Hebei, China Liang, Di Shi, Jin Li, Daojuan Wu, Siqi Jin, Jing He, Yutong Front Oncol Oncology OBJECTIVE: Lung cancer screening has been widely conducted in Western countries. However, population-based lung cancer screening programs in Hebei in China are sparse. Our study aimed to assess the participation rate and detection rate of positive nodules and lung cancer in Hebei province. METHOD: In total, 228 891 eligible participants aged 40–74 years were enrolled in the Cancer Screening Program in Hebei from 2013 to 2019. A total of 54 846 participants were evaluated as the lung cancer high-risk population by a risk score system which basically followed the Harvard Risk Index and was adjusted for the characteristics of the Chinese population. Then this high-risk population was recommended for low-dose computed tomography (LDCT) screening. And all participants attended annual passive follow-up, and the active follow-up interval was based on radiologist’s suggestion. All participants were followed-up until December 31, 2020. The overall, group-specific participation rates were calculated, and its associated factors were analyzed by a multivariable logistic regression model. Participation rates and detection of positive nodules and lung cancer were reported. RESULTS: The overall participation rate was 52.69%, where 28 899 participants undertook LDCT screening as recommended. The multivariable logistic regression model demonstrated that a high level of education, having disease history, and occupational exposure were found to be associated with the participation in LDCT screening. The median follow-up time was 3.56 person-years. Overall, the positive identification of lung nodules and suspected lung cancer were 12.73% and 1.46% through LDCT screening. After the native and passive follow-up, 257 lung cancer cases were diagnosed by lung cancer screening, and the detection rate of lung cancer was 0.89% in the screening group. And its incidence density was 298.72 per 100,000. Positive lung nodule rate and detection rate were increased with age. CONCLUSION: Our study identified personal and epidemiological factors that could affect the participation rate. Our findings could provide the guideline for precise prevention and control of lung cancer in the future. Frontiers Media S.A. 2022-01-10 /pmc/articles/PMC8784378/ /pubmed/35083151 http://dx.doi.org/10.3389/fonc.2021.795528 Text en Copyright © 2022 Liang, Shi, Li, Wu, Jin and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liang, Di
Shi, Jin
Li, Daojuan
Wu, Siqi
Jin, Jing
He, Yutong
Participation and Yield of a Lung Cancer Screening Program in Hebei, China
title Participation and Yield of a Lung Cancer Screening Program in Hebei, China
title_full Participation and Yield of a Lung Cancer Screening Program in Hebei, China
title_fullStr Participation and Yield of a Lung Cancer Screening Program in Hebei, China
title_full_unstemmed Participation and Yield of a Lung Cancer Screening Program in Hebei, China
title_short Participation and Yield of a Lung Cancer Screening Program in Hebei, China
title_sort participation and yield of a lung cancer screening program in hebei, china
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784378/
https://www.ncbi.nlm.nih.gov/pubmed/35083151
http://dx.doi.org/10.3389/fonc.2021.795528
work_keys_str_mv AT liangdi participationandyieldofalungcancerscreeningprograminhebeichina
AT shijin participationandyieldofalungcancerscreeningprograminhebeichina
AT lidaojuan participationandyieldofalungcancerscreeningprograminhebeichina
AT wusiqi participationandyieldofalungcancerscreeningprograminhebeichina
AT jinjing participationandyieldofalungcancerscreeningprograminhebeichina
AT heyutong participationandyieldofalungcancerscreeningprograminhebeichina